Skip to main content
SpringerLink
Log in

The oral insulin sensitiser INS-1 improves ovulation and has beneficial cardiovascular effects in lean women with polycystic ovary syndrome

  • Media release
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

The oral insulin sensitiser INS-1 improves ovulation and has beneficial cardiovascular effects in lean women with polycystic ovary syndrome. Inpharma Wkly. 1245, 12 (2000). https://doi.org/10.2165/00128413-200012450-00026

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-200012450-00026

Keywords

Search

Navigation